Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) Files An 8-K

Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) announces it has appointed Davidson and Company, LLP, Chartered Professional Accountants, as its new independent registered public auditing firm for its fiscal year ending August 31, 2016.

Story continues below

There were no reservations nor any modified opinions expressed in the Former Auditor’s reports on any of the Company’s financial statements relating to the period commencing at the beginning of the Company’s two most recently completed financial years and ending on the date of resignation. In the opinion of the Company’s Audit Committee and Board of Directors, there are no reportable events between the Company and the Former Auditors. Lexaria thanks its former auditing firm for their work, and looks forward to its new relationship with Davidson and Company LLP.

Shareholders will be asked to ratify the appointment of Davidson and Company, LLP, at the next annual general meeting of the Company.

About Lexaria

Lexaria Bioscience Corp. is a food Sciences Company focused on the delivery of active compounds that can behave as superfoods through its proprietary infusion technologies. Lexaria’s technology enables higher bioavailability rates for CBD; THC; NSAIDs; Nicotine and other molecules than is possible without lipophilic enhancement technology. This can allow for lower overall dosing requirements and/or higher effectiveness in active molecule delivery. Lexaria hopes to reduce other common but less healthy ingestion methods such as smoking as it embraces the benefits of public health. www.lexariaenergy.com

An ad to help with our costs